Successful Treatment of Eczema-Like Mucormycosis in a Child by Combination of Intravenous Drip and Percutaneous Injection Amphotericin B
- 17 Downloads
We report a case of eczema-like cutaneous mucormycosis caused by Rhizopus arrhizus. A 4-year-old child was presented to our hospital with a history of gradually enlarging papule and plaque in the periumbilical area for nearly 4 years since 2 weeks after his birth, and it has been misdiagnosed as eczema for nearly 3 years. Based on histopathology examination, the fungus culture test and DNA sequencing, it was revealed that R. arrhizus should be the responsible fungus for skin infection. The patient was successfully cured by combination of intravenous drip and percutaneous injection amphotericin B for nearly 3 months, and no recrudescence was seen during a follow-up of 6-month observation.
KeywordsMucormycosis Rhizopus Child Eczema-like
This study was funded by Special Program for Basic work of science and technology, funded by the Ministry of Science and Technology of China (2013FY113700), supported by National Natural Science Foundation of China (81471905) and was funded by the Chinese Academy Medical Sciences Initiative for Innovative Medicine (2016-I2M-3-021).
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from all individual participants included in the study.
- 2.Barratt DM, Van Meter K, Asmar P, Nolan T, Trahan C, Garcia-Covarrubias L, et al. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother. 2001;45(12):3601–2. https://doi.org/10.1128/AAC.45.12.3601-3602.2001.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard-Second Edition. CLSI document M38-A2. Wayne, PA: Clinical and Laborary Standards Institute; 2008.Google Scholar
- 7.Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, et al. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis. 2016;16(1):667. https://doi.org/10.1186/s12879-016-2005-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Zhang AP, Liu W, Hu B. Cutaneous mucormycosis due to Rhizopus arrhizus: report 3 cases. J Clin Dermatol. 2012;41(3):163–5 (in Chinese with English abstract).Google Scholar
- 15.Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(Suppl 3):5–26. https://doi.org/10.1111/1469-0691.12371.CrossRefGoogle Scholar
- 16.Martin LB, Rodriguez MAM, Mercier N, Lafont MO, Fernandez EO, de la Parte AR, et al. Rhizopus arrhizus invasive infection due to self-inflicted scratch injuries in a diabetic patient with non-ketotic acidosis. Mycopathologia. 2017;182(9–10):927–31. https://doi.org/10.1007/s11046-017-0158-0.CrossRefPubMedGoogle Scholar
- 20.De Decker K, Van Poucke S, Wojciechowski M, Ieven M, Colpaert C, Vogelaers D, et al. Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2006;7(5):482–5. https://doi.org/10.1097/01.pcc.0000235255.68759.05.CrossRefGoogle Scholar
- 22.Wildenbeest JG, Oomen MW, Bruggemann RJ, de Boer M, Bijleveld Y, van den Berg JM, et al. Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease. Pediatr Infect Dis J. 2010;29(6):578. https://doi.org/10.1097/INF.0b013e3181dc8352.CrossRefPubMedGoogle Scholar
- 24.Zhang DL. Nursing experience of one child with disseminated cryptococcosis. Sichuan Med J. 2005;26(6):697–8 (in Chinese).Google Scholar